Molecule intelOpportunity: StrongEssential

Leuprorelin

10 brands · 8 companies · product forms

ATC: L02AE02

Opportunity snapshot

Launch attractiveness
51
Market saturation
21
Price room
100
Regulatory risk
0
10
brands
8
companies
Rs 36,504.09
median price
11
price points
6.05x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 20%

Price room

Across observed sources and strengths
CheapestRs 10,679.52
MedianRs 36,504.09
Most expensiveRs 64,630.49
Spread6.05×
Sources: DRAP-official, Servaid

max/min price ratio 6.05x across 11 trusted points (Rs 10679.52-64630.49). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 2 live products for Leuprorelin — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(79) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

8 canonical companies and 10 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 6.05x across 11 trusted points (Rs 10679.52-64630.49). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.